From: LH Dynamics in Overweight Girls with Premature Adrenarche and Slowly Progressive Sexual Precocity
 | Premature Adrenarche | SPPOPA | OW-PUB | PRE Reference Range [20] | ||||
---|---|---|---|---|---|---|---|---|
 | Basal | Post-GnRHag | Basal | Post-GnRHag | Basal | Post-GnRHag | Basal | Post-GnRHag |
LH | 0.15  0.8 | 3.1  0.8 | 0.15  0.0 | 9.8  2.7 | 2.0  1.0 | 38  8.5 | <0.15 | 1.0–7.0 |
(U/L) | (0.15) | (0.8–5.9) | (0.15) | (4.3–19) | (0.2–8.2) | (4.8–76) |  |  |
FSH | 1.4  0.2 | 21.4  3.9 | 1.1  0.2 | 26.4  7.3 | 3.1  0.7 | 24.9  2.7 | 0.4–1.7 | 7.9–32 |
(U/L) | (0.9–2.2) | (9.1–42) | (0.6–1.8) | (23–52) | (0.5–6.1) | (16.5–32) |  |  |
LH/FSH | 0.12  0.01 | 0.16  0.04 | 0.16  0.03 | 0.53  0.23 | 0.46  0.18 | 1.7  0.50 | 0.09–0.43 | 0.04–0.28 |
(Ratio) | (0.07–0.17) | (0.05–0.31) | (0.08–0.25) | (0.10–1.4) | (0.09–1.6) | (0.15–4.5) |  |  |
E2 | 6.0  1.8 | 25.8  3.2 | 6.5  0.5 | 52.8  13.1 | 19.0  4.5 | 134  34.1 | ≤5.0–7.0 | 7.0–49 |
(pg/mL) | (≤5.0–10) | (16–39) | (≤5.0–8.0) | (19–95) | (≤5.0–39) | (23–298) |  |  |
PROG | ≤25  0.0 | ≤25  0.0 | ≤25  0.0 | ≤25  0.0 | ≤25  0.0 | 29.8  2.6 | ≤25 | ≤25 |
(ng/dl) | (25) | (25) | (25) | (25) | (25) | (25–44) |  |  |
17OHP | ≤25  0.0 | ≤25  0.0 | ≤25  0.0 | 25.8  0.4 | ≤25  0.0 | 73.0  18.2 | ≤25 | ≤25 |
(ng/dl) | (25) | (25) | (25) | (25–27) | (25) | (25–172) |  |  |
DHEA | 121  20.3 | 98.2  9.5 | 105  21 | 80.8  9.9 | 92.5  17.6 | 89.6  10.6 | 28–59 | 27–69 |
(ng/dl) | (67–212) | (77–129) | (50–162) | (42–96) | (41–158) | (44–125) |  |  |
A'dione | 30.1  3.8 | 28.0  1.6 | 28.4  3.4 | 37.9  8.9 | 43.9  7.9 | 76.6  17.4 | ≤25 | 25–40 |
(ng/dl) | (≤25–52) | (25–35) | (25–42) | (25–72) | (25–88) | (25–169) |  |  |
Total T | ≤10  0.0 | ≤10  0.0 | 12.2  2.3 | 11.5  0.6 | 15.2  2.4 | 18.3  3.5 | ≤10 | ≤10 |
(ng/dl) | (≤10) | (≤10) | (10–19) | (10–13) | (10–30) | (10–40) |  |  |
Cortisol | 2.0  0.3 | 1.6  0.2 | 2.0  0.3 | 1.5  0.3 | 2.0  0.6 | 1.5  0.3 | 1.0–3.0 | 1.0–5.0 |
(g/dl) | (1.0–3.0) | (1.0–2.0) | (1.0–3.0) | (0.9–2.0) | (0.9–2.0) | (0.9–3.0) |  |  |